New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 15, 2013
10:12 EDTUGI, STJ, LOGM, END, ANGI, TROW, ICE, ECA, RIG, GOLD, HBAN, DVA, RDY, GM, LINE, APA, STI, MWW, EXR, CMA, CTL, CSTR, EADSYOn the Fly: Analyst Downgrade Summary
Today’s noteworthy downgrades include: Angie's List (ANGI) downgraded to Market Perform from Outperform at Barrington... Comerica (CMA) downgraded to Sell from Neutral at Citigroup... DaVita (DVA) downgraded to Neutral from Buy at Goldman... Endeavour (END) downgraded to Hold from Buy at C.K. Cooper... Extra Space Storage (EXR) downgraded to Sell from Neutral at UBS... Gold Fields (GFI) downgraded to Sector Underperformer from Sector Performer at CIBC... Huntington Bancshares (HBAN) downgraded to Neutral from Buy at Citigroup... LogMeln (LOGM) downgraded to Neutral from Overweight at JPMorgan... Monster Worldwide (MWW) downgraded to Neutral from Buy at SunTrust... Randgold Resources (GOLD) downgraded to Sell from Neutral at Citigroup... St. Jude Medical (STJ) downgraded to Underperform from Neutral at Cowen... SunTrust (STI) downgraded to Hold from Buy at Jefferies... Transocean (RIG) downgraded to Sell from Hold at Deutsche Bank... UGI Corporation (UGI) downgraded to Neutral from Buy at UBS... Apache (APA) downgraded to Neutral from Outperform at Macquarie... Encana (ECA) downgraded to Neutral from Buy at UBS... EADS (EADSY) downgraded to Market Perform from Outperform at Bernstein... LINN Energy (LINE) downgraded to Sector Perform from Outperform at Howard Weil... IntercontinentalExchange (ICE) downgraded to Neutral from Buy at Compass Point... Coinstar (CSTR) downgraded to Neutral from Buy at Compass Point... General Motors (GM) downgraded to Hold from Buy at Craig-Hallum... T. Rowe Price (TROW) downgraded to Neutral from Positive at Susquehanna... CenturyLink (CTL) downgraded to Hold from Buy at Argus... Dr. Reddy's Labs (RDY) downgraded to Neutral from Buy at BofA/Merrill.
News For ANGI;CMA;DVA;END;EXR;HBAN;LOGM;MWW;GOLD;STJ;STI;RIG;UGI;APA;ECA;EADSY;LINE;ICE;CSTR;GM;TROW;CTL;RDY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
March 18, 2015
07:04 EDTECAEncana upgraded to Buy from Hold at Desjardins
05:39 EDTSTJSt. Jude Medical downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded St. Jude Medical (STJ) to Market Perform saying competitive pressures will drive 2015 market share losses in the company's cardiac rhythm management business, which represents 50% of total sales. Wells believes the launch of CardioMEMS will not be strong enough to offset the headwinds in CRM unit. The firm thinks Boston Scientific's (BSX) earlier than expected approval for its next generation subcutaneous implantable cardioverter-defibrillator called Emblem will drive share gains against St. Jude and Medtronic (MDT) in the single chamber ICD market. Wells cut its price target range for St. Jude shares to $69-$70 from $73-$74. The medical technology company closed yesterday down $2.01 to $65.45.
March 17, 2015
16:00 EDTRIGOptions Update; March 17, 2015
iPath S&P 500 VIX Short-Term Futures down 11c to 27.30. Option volume leaders: AAPL RIG MGM HTZ TWTR TSLA CY KO NFLX C according to Track Data.
14:13 EDTGMMorgan Stanley questions GM capital allocation plan
Subscribe for More Information
08:05 EDTGMGeneral Motors coverage resumed with an Underweight at Morgan Stanley
Morgan Stanley reinstated General Motors with an Underweight and $28 price target. The firm believes GM's agreement to accelerate capital returns to investors is a popular short-term decision but raises questions longer-term by increasing both financial and strategic risks.
07:20 EDTANGIBofA/Merrill to hold a conference
Smid Cap Conference 2015 is being held in Boston on March 17-18.
07:18 EDTEADSYSatellite & Access Intelligence to hold a exhibition
Subscribe for More Information
06:23 EDTGMGM employees to be deposed for class action case, NY Times says
Subscribe for More Information
06:02 EDTHBANHuntington Bancshares to add 250 jobs in Michigan
Subscribe for More Information
March 16, 2015
13:21 EDTEADSYAirbus selected to develop next generation helicopters for South Korea
Subscribe for More Information
13:16 EDTSTJAnalysts upbeat on results of Edwards' Sapien 3 data
The shares of Edwards Lifesciences (EW) are rising after the company released data on its Sapien 3 transcathter aortic valve over the weekend. In notes to investors today, a number of analysts were upbeat on the data. BACKGROUND: Edwards yesterday announced that high- and intermediate-risk patients treated with Sapien 3 demonstrated lower mortality rates than patients treated with previous transcathter aortic valves, or TAVR, made by the company. The patients also had excellent clinical outcomes in the other primary endpoints of stroke and paravalvular regurgitation, the company stated. Meanwhile, a five year study of patients treated with the first generation SAPIEN device showed that the patients had equivalent outcomes to traditional open-heart surgery, and no structural valve deterioration requiring intervention, the company stated. ANALYST REACTION: Edwards' Sapien 3 data was impressive, as the device showed one of the lowest stroke and mortality rates of any major TAVR study so far, Bernstein analyst Derrick Sung wrote in a note to investors earlier today. Data presented by Edwards and other companies at the American College of Cardiology, or ACC, conference this weekend caused investors and the medical community to become more optimistic about the potential for TAVR devices to replace surgical valves, Sung stated. The analyst wrote that he continues to believe that investors are underestimating the potential size of the TAVR market. Also upbeat on Edwards' data was Wells Fargo, which wrote that the data exceeded high expectations and could pressure the FDA to approve Sapien 3 for intermediate risk patients earlier than Edwards' guidance of late 2016. WHAT'S NOTABLE: Analysts were also upbeat on data reported by other companies at the ACC conference. Medtronic's (MDT) data suggested that its CoreValve Evolut-R product may be as effective as Edwards' Sapien 3, Bernstein's Sung stated. The FDA appears to have allowed Boston Scientific's (BSX) left atrial appendage closure, Watchman, to be provided to more patients than expected, research firm Stifel believes. Meanwhile, St. Jude's (STJ) CardioMEMS device yielded "impressive" mortality data, the firm added. Stifel kept Buy ratings on both Medtronic and St. Jude. PRICE ACTION: In early afternoon trading, Edwards Lifesciences climbed 9% to $147.64, Boston Scientific advanced 4% to $17.27, St. Jude added 2% to $67.55, and Medtronic rose 1.3% to $77.50.
11:47 EDTICECFTC orders ICE Futures U.S. to pay $3M civil monetary penalty
Subscribe for More Information
11:06 EDTGMGM ignition switch death claims rises to 67, WSJ says
Subscribe for More Information
10:02 EDTGOLDOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AmerisourceBergen (ABC) upgraded to Buy from Neutral at UBS... Avago (AVGO) upgraded to Buy from Neutral at DA Davidson... Francesca's (FRAN) upgraded to Buy at Janney Capital... Goldcorp (GG) upgraded to Overweight from Neutral at HSBC... Jabil Circuit (JBL) upgraded to Buy from Hold at Cross Research... JetBlue (JBLU) upgraded to Outperform at Raymond James... King Digital (KING) upgraded to Overweight from Neutral at JPMorgan... L.B. Foster (FSTR) upgraded to Outperform from Neutral at Macquarie... NextEra Energy (NEE) upgraded to Buy from Hold at Deutsche Bank... Petrobras Argentina (PZE) upgraded to Buy from Neutral at BofA/Merrill... Qorvo (QRVO) upgraded to Buy from Neutral at DA Davidson... Randgold (GOLD) upgraded to Overweight from Neutral at HSBC... Royal Gold (RGLD) upgraded to Overweight from Neutral at HSBC... Seagate (STX) upgraded at Needham... Standex (SXI) upgraded to Buy from Hold at BB&T... Union Pacific (UNP) upgraded to Outperform from Neutral at Macquarie... West Corp. (WSTC) upgraded to Outperform from Neutral at RW Baird... Xilinx (XLNX) upgraded to Buy from Hold at Drexel Hamilton... YPF (YPF) upgraded to Buy from Neutral at BofA/Merrill.
10:00 EDTEADSYRyanair plans transatlantic service in four to five years, Financial Times says
Subscribe for More Information
09:19 EDTCMAComerica management to meet with JPMorgan
Subscribe for More Information
08:05 EDTSTJSt. Jude Medical data 'impressive,' says BMO Capital
Subscribe for More Information
06:12 EDTGOLDRandgold upgraded to Overweight from Neutral at HSBC
Subscribe for More Information
06:03 EDTEADSYAirbus Helicopters expected to sign $3B contract in South Korea, Reuters reports
Subscribe for More Information
06:00 EDTICENYSE owner warns of cyber risk to frequency trading, Financial Times says
IntercontinentalExchange CEO Jeff Sprecher warned that efforts to fend off cyber hackers could reverse the momentumtowards faster markets, reports the Financial Times. Sprecher adds that the growing risk of cyber attacks would force traders to pass new electronic sentries as they connect to his exchanges. Reference Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use